Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) – Data of a prospective traveller study

Rogers, 2011, Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain, J Antimicrob Chemother, 66, 1, 10.1093/jac/dkq415 van der Bij, 2012, The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae, J Antimicrob Chemother, 67, 2090, 10.1093/jac/dks214 Hassing, 2015, International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review, Euro Surveill, 20, 10.2807/1560-7917.ES.2015.20.47.30074 Kuenzli, 2016, Antibiotic resistance and international travel: Causes and consequences, Travel Med Infect Dis, 14, 595, 10.1016/j.tmaid.2016.11.010 Woerther, 2017, Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level, J Travel Med, 10.1093/jtm/taw101 Tham, 2010, Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea, Scand J Infect Dis, 42, 275, 10.3109/00365540903493715 Tängden, 2010, Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers, Antimicrob Agents Chemother, 54, 3564, 10.1128/AAC.00220-10 Östholm-Balkhed, 2013, Travel Study Group of Southeast Sweden. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors, J Antimicrob Chemother, 68, 2144, 10.1093/jac/dkt167 Paltansing, 2013, Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from The Netherlands, Emerg Infect Dis, 19, 1206, 10.3201/eid1908.130257 Kuenzli, 2014, High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors, BMC Infect Dis, 14, 528, 10.1186/1471-2334-14-528 Kantele, 2015, Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae, Clin Infect Dis, 60, 837, 10.1093/cid/ciu957 Angelin, 2015, Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: a prospective study, Travel Med Infect Dis, 13, 223, 10.1016/j.tmaid.2015.04.007 Ruppe, 2015, High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics, Clin Infect Dis, 61, 593, 10.1093/cid/civ333 Reuland, 2016, Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum beta-lactamase-producing Enterobacteriaceae - a prospective cohort study, Clin Microbiol Infect, 22 Arcilla, 2017, Import and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study, Lancet Infect Dis, 17, 78, 10.1016/S1473-3099(16)30319-X Pitzurra, 2010, Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations, BMC Infect Dis, 10, 231, 10.1186/1471-2334-10-231 Belderok, 2011, Schim van der Loeff MF, Sonder GJ. Incidence, risk factors and treatment of diarrhoea among Dutch travellers: reasons not to routinely prescribe antibiotics, BMC Infect Dis, 11, 295, 10.1186/1471-2334-11-295 Stenderup, 1983, Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea, Scand J Infect Dis, 15, 367, 10.3109/inf.1983.15.issue-4.07 Murray, 1982, Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim–sulfamethoxazole, N Engl J Med, 306, 130, 10.1056/NEJM198201213060302 Sullivan, 2001, Effect of antimicrobial agents on the ecological balance of human microflora, Lancet Infect Dis, 1, 101, 10.1016/S1473-3099(01)00066-4 Jernberg, 2010, Long-term impacts of antibiotic exposure on the human intestinal microbiota, Microbiology, 156, 3216, 10.1099/mic.0.040618-0 Paterson, 2008, Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy, Clin Infect Dis, 47, S14, 10.1086/590062 Vilkman, 2016, Travelers' health problems and behavior: prospective study with post-travel follow-up, BMC Infect Dis, 16, 328, 10.1186/s12879-016-1682-0 Lääveri, 2016, Prospective study of pathogens in asymptomatic travellers and those with diarrhoea: aetiological agents revisited, Clin Microbiol Infect, 22, 535, 10.1016/j.cmi.2016.02.011 European committee on antimicrobial susceptibility testing (EUCAST), 2016 Strysko, 2016, International travel is a risk factor for extended-spectrum beta-lactamase-producing Enterobacteriaceae acquisition in children: a case-case-control study in an urban U.S. hospital, Travel Med Infect Dis, 14, 568, 10.1016/j.tmaid.2016.11.012 Youmans, 2015, Characterization of the human gut microbiome during travelers' diarrhea, Gut Microbes, 6, 110, 10.1080/19490976.2015.1019693 Kantele, 2015, As far as travelers' risk of acquiring resistant intestinal microbes is considered, no antibiotics (absorbable or nonabsorbable) are safe, Clin Infect Dis, 60, 1872, 10.1093/cid/civ174 Stamm, 1980, Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial, Ann Intern Med, 92, 770, 10.7326/0003-4819-92-6-770 Moller, 1984, The influence of long-term treatment with mecillinam on fecal Escherichia coli, Scand J Infect Dis, 16, 223, 10.3109/00365548409087147 Canton, 2012, CTX-M enzymes: origin and diffusion, Front Microbiol, 3, 110, 10.3389/fmicb.2012.00110 Ranjan, 2015, Genomic and functional portrait of a highly virulent, CTX-M-15-producing H30-Rx subclone of Escherichia coli sequence type 131, Antimicrob Agents Chemother, 59, 6087, 10.1128/AAC.01447-15 Sader, 2009, Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals, Diagn Microbiol Infect Dis, 2014, 443 Ruppe, 2015, Mechanisms of antimicrobial resistance in gram-negative bacilli, Ann Intensive Care, 5, 61, 10.1186/s13613-015-0061-0 Kantele, 2015, A call to restrict prescribing antibiotics for travellers' diarrhea–travel medicine practitioners can play an active role in preventing the spread of antimicrobial resistance, Travel Med Infect Dis, 13, 213, 10.1016/j.tmaid.2015.05.005 Lääveri, 2016, Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea, Travel Med Infect Dis, 14, 299, 10.1016/j.tmaid.2016.06.006 Kantele, 2016, Increased risk for ESBL-producing bacteria from co-administration of loperamide and antimicrobial drugs for travelers' diarrhea, Emerg Infect Dis, 22, 117, 10.3201/eid2201.151272